High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao(Tiangong University), Zongyao Wang(Novartis (China)), Christian Schnell(Novartis (Switzerland)), Youzhen Wang(Novartis (China)), John E. Monahan, Colleen Kowal(Novartis Foundation), Jason J. Merkin(Novartis Foundation), Rebecca Leary(Howard Hughes Medical Institute), Roberto Velazquez(Novartis Foundation), Fabian Von Arx(Novartis (Switzerland)), O. Alejandro Balbin(Novartis (United States)), Shannon Chuai(Novartis (China)), Fernando Salangsang(Novartis (Switzerland)), Ernesta Dammassa(Novartis (Switzerland)), Stéphane Ferretti(Novartis (Switzerland)), Anupama Reddy(Rutgers, The State University of New Jersey), Sonja Tobler(Novartis (Switzerland)), Hongbo Cai(Novartis Foundation), Alice Loo, Stéphanie Barbé(Novartis (Switzerland)), Nicolas Ebel(Novartis (Switzerland)), Fergal Casey(Novartis (Switzerland)), Mallika Singh(Revolution Medicines (United States)), Walter Tinetto(Novartis (Switzerland)), K. Venkatesan(Harvard University), Joshua M. Korn(Novartis (United States)), Derek Y. Chiang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Scott D. Collins(Novartis Foundation), E. Robert McDonald(Novartis (Switzerland)), David A. Ruddy(Novartis (Switzerland)), Edward Lorenzana(Novartis (Switzerland)), Montesa Patawaran(Novartis (Switzerland)), Hui Qin Wang(Genomics Institute of the Novartis Research Foundation), Joseph Lehár(Whitehead Institute for Biomedical Research), Claudia Röelli(Novartis (Switzerland)), Chao Zhang(Novartis (China)), Yan Tang(Shanghai East Hospital), Yun Zhang(Novartis (China)), Angad Singh(Novartis Foundation), Ronald A. Meyer(Novartis (Switzerland)), Guizhi Yang(Novartis Foundation), Francesca Santacroce(Novartis (Switzerland)), Shawn Cogan(Novartis Foundation), Margaret E. McLaughlin(Novartis (Switzerland)), Tara L. Naylor(Novartis (Switzerland)), Audrey Kauffmann(Novartis (Switzerland)), John Green(Novartis Foundation), Millicent Embry(Novartis (Switzerland)), Ying Liang(Novartis (China)), Susmita Chatterjee(Novartis (Switzerland))
Cited by 1,438
Related Papers
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k